Video

Factors Informing Adjuvant Treatment Selection in HER2+ Early Breast Cancer

A look at how patient response to neoadjuvant treatment for HER2+ early breast cancer informs adjuvant treatment selection.

Video Player is loading.
Current Time 0:00
Duration 4:32
Loaded: 0%
Stream Type LIVE
Remaining Time 4:32
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected